(Q46472442)

English

Phase I trial of BAY 50-4798, an interleukin-2-specific agonist in advanced melanoma and renal cancer.

scientific article published in June 2007

Statements

Phase I trial of BAY 50-4798, an interleukin-2-specific agonist in advanced melanoma and renal cancer (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit